These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24618888)

  • 1. Profile and response to anti-tuberculosis treatment among elderly tuberculosis patients treated under the TB Control programme in South India.
    Velayutham BR; Nair D; Chandrasekaran V; Raman B; Sekar G; Watson B; Charles N; Malaisamy M; Thomas A; Swaminathan S
    PLoS One; 2014; 9(3):e88045. PubMed ID: 24618888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?
    Dave P; Vadera B; Kumar AM; Chinnakali P; Modi B; Solanki R; Patel P; Patel P; Pujara K; Nimavat P; Shah A; Bharaswadkar S; Rade K; Parmar M; Nair SA
    PLoS One; 2015; 10(4):e0121996. PubMed ID: 25874545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile and treatment outcomes of elderly patients with tuberculosis in Delhi, India: implications for their management.
    Patra S; Lukhmana S; Tayler Smith K; Kannan AT; Satyanarayana S; Enarson DA; Nagar RK; Marcel M; Reid T
    Trans R Soc Trop Med Hyg; 2013 Dec; 107(12):763-8. PubMed ID: 24189479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
    Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
    AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
    Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
    BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis-diabetes epidemiology in the border and non-border regions of Tamaulipas, Mexico.
    Abdelbary BE; Garcia-Viveros M; Ramirez-Oropesa H; Rahbar MH; Restrepo BI
    Tuberculosis (Edinb); 2016 Dec; 101S():S124-S134. PubMed ID: 27733244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of profile and treatment outcomes between elderly and non-elderly tuberculosis patients in Puducherry and Tamil Nadu, South India.
    Murali S; Krishnamoorthy Y; Knudsen S; Roy G; Ellner J; Horsburgh CR; Hochberg N; Salgame P; Prakash Babu S; Sarkar S
    PLoS One; 2021; 16(8):e0256773. PubMed ID: 34449817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antituberculosis drug-resistance surveillance as a tool for tuberculosis control programmes: a retrospective study.
    La Raja M; Screm C; Talmassons G; Pasquadibisceglie A; Pitzalis G; Pitzus E
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):450-4. PubMed ID: 9510665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of clinical profile of cases of MDR-TB and evaluation of challenges faced in initiation of second line Anti tuberculosis treatment for MDR-TB cases admitted in drug resistance tuberculosis center.
    Mukati S; Julka A; Varudkar HG; Singapurwala M; Agrawat JC; Bhandari D; Jain A
    Indian J Tuberc; 2019 Jul; 66(3):358-363. PubMed ID: 31439180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-administered tuberculosis treatment outcomes in a tribal population on the indo-myanmar border, Nagaland, India.
    Das M; Isaakidis P; Shenoy R; Anicete R; Sharma HK; Ao I; Osah K; Mansoor H; Saranchuk P; Abraham S
    PLoS One; 2014; 9(9):e108186. PubMed ID: 25259868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
    Velayutham B; Chadha VK; Singla N; Narang P; Gangadhar Rao V; Nair S; Ramalingam S; Narayanan Sivaramakrishnan G; Joseph B; Selvaraju S; Shanmugam S; Narang R; Pachikkaran P; Bhat J; Ponnuraja C; Bajaj Bhalla B; Shivashankara BA; Sebastian G; Yadav R; Kumar Sharma R; Sarin R; Myneedu VP; Singla R; Khayyam K; Mrithunjayan SK; Jayasankar SP; Sanker P; Viswanathan K; Viswambharan R; Mathuria K; Bhalla M; Singh N; Tumane KB; Dawale A; Tiwari CP; Bansod R; Jayabal L; Murali L; Khaparde SD; Rao R; Jawahar MS; Natrajan M
    PLoS One; 2018; 13(7):e0200150. PubMed ID: 29979738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High rates of ofloxacin resistance in Mycobacterium tuberculosis among both new and previously treated patients in Tamil Nadu, South India.
    Selvakumar N; Kumar V; Balaji S; Prabuseenivasan S; Radhakrishnan R; Sekar G; Chandrasekaran V; Kannan T; Thomas A; Arunagiri S; Dewan P; Swaminathan S
    PLoS One; 2015; 10(3):e0117421. PubMed ID: 25738956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB.
    Mishra B; Rockey SM; Gupta S; Srinivasa H; Muralidharan S
    Trop Doct; 2012 Jan; 42(1):35-7. PubMed ID: 22080484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000.
    Santha T; Garg R; Frieden TR; Chandrasekaran V; Subramani R; Gopi PG; Selvakumar N; Ganapathy S; Charles N; Rajamma J; Narayanan PR
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):780-8. PubMed ID: 12234133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 20. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.